Gene · 5172
Papers3,149
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,149
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive benchmarking of genome editing quantification methods for plant applications. | iScience | 2025 | 40487430 | PubTator, text mining | PubMed |
| Modeling a Standard Loop-Mediated Isothermal Amplification Reaction and Its Modification Involving Additional Inner Primers. | Biomolecules | 2025 | 40427583 | PubTator, text mining | PubMed |
| Genetic heterogeneity in patients with enlarged vestibular aqueduct and Pendred syndrome. | Mol Med | 2025 | 40426046 | PubTator, text mining | PubMed |
| [Molecular genetics in pediatric endocrinology: 35 years of research]. | Probl Endokrinol (Mosk) | 2025 | 40411325 | PubTator, text mining | PubMed |
| An all-in-one plant virus-based vector toolkit for streamlined gene silencing, overexpression, and genome editing. | Plant Commun | 2025 | 40394900 | PubTator, text mining | PubMed |
| Clinical application of preimplantation genetic testing based on low-coverage next-generation sequencing with linkage analyses in hereditary hearing loss families. | J Assist Reprod Genet | 2025 | 40389765 | PubTator, text mining | PubMed |
| Recurrent and Novel Pathogenic Variants in Genes Involved with Hearing Loss in the Pakistani Population. | Mol Diagn Ther | 2025 | 40377830 | PubTator, text mining | PubMed |
| The Diverse Genetic Landscape of Hearing Impairment in South African Families. | Clin Genet | 2025 | 40371963 | PubTator, text mining | PubMed |
| Design, synthesis, herbicidal activity, and the molecular docking study of novel phenylpyrazole derivatives with strobilurin moieties. | RSC Adv | 2025 | 40370840 | PubTator, text mining | PubMed |
| From deficiency to excess: the impact of iodine excess on reproductive health. | Front Endocrinol (Lausanne) | 2025 | 40370779 | PubTator, text mining | PubMed |
| Lomibuvir sensitizes radioiodine-resistant thyroid cancer cell lines to radioiodine treatment by targeting hTERT RNA-dependent polymerase activity. | J Endocrinol Invest | 2025 | 40358852 | PubTator, text mining | PubMed |
| Dmrt2 and Hmx2 direct intercalated cell diversity in the mammalian kidney through antagonistic and supporting regulatory processes. | Proc Natl Acad Sci U S A | 2025 | 40354537 | PubTator, text mining | PubMed |
| Reclassification of candidate splicing variants refines clinically conflicting interpretations in SLC26A4-associated hearing loss. | J Med Genet | 2025 | 40350251 | PubTator, text mining | PubMed |
| Targeted sequencing identifies 33 novel mutations in 130 ClinGen curated hearing loss genes among 253 pediatric patients: A retrospective case study. | Biomed Rep | 2025 | 40322553 | PubTator, text mining | PubMed |
| Spectrum and Frequencies of Genes for Inherited Hearing Loss in Southwestern Chinese Families. | Genet Test Mol Biomarkers | 2025 | 40300787 | PubTator, text mining | PubMed |
| SLC26A4 C.317C > A Variant: Functional Analysis and Patient-Derived Induced Pluripotent Stem Line Development. | Mol Genet Genomic Med | 2025 | 40260864 | PubTator, text mining | PubMed |
| [Clinical application of next-generation sequencing in early screening of neonatal diseases]. | Zhongguo Dang Dai Er Ke Za Zhi | 2025 | 40241361 | PubTator, text mining | PubMed |
| Using T7 endonuclease I to detect SLC26A4 mutations in children with large vestibular aqueduct syndrome, with or without Mondini malformation and assess cochlear implant outcomes. | Eur Arch Otorhinolaryngol | 2025 | 40195191 | PubTator, text mining | PubMed |
| Optical Probes for Cellular Imaging of G-quadruplexes: Beyond Fluorescence Intensity Probes. | Angew Chem Int Ed Engl | 2025 | 40192564 | PubTator, text mining | PubMed |
| The Human Thyroid-Derived CI-huThyrEC Cell Line Expresses the Thyrotropin (TSH) Receptor and Thyroglobulin but Lacks Other Essential Characteristics of Thyroid Follicular Cells. | Biomolecules | 2025 | 40149910 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5172/papers?page=8